Women's Health Wearables and Femtech Devices Patent Landscape Analysis Report 2026 Edition

Women's Health Wearables and Femtech Devices Market Size, Growth Trends, and Industry Outlook

Women's health wearables and femtech devices cover rings, wristbands, patches, breast pumps and pelvic trainers that collect physiological signals linked to the menstrual cycle, fertility, pregnancy, lactation, menopause and pelvic health. Consumers drive demand directly, since most products are bought online and paired with a smartphone application. Clinical use is growing as obstetric and fertility teams accept wearable data in care pathways.

The market growth is driven by the spread of overnight skin temperature sensing in rings and watches, which gives cycle and fertility applications daily data without a manual thermometer. WHO reported in 2023 that about one in six people of reproductive age experience infertility, a base of potential users for fertility tracking.

WHO estimates 13.4 million preterm births in 2020, which keeps maternal and fetal monitoring a priority for health systems and supports clinical interest in wearable pregnancy tools. The agency also projects 1.2 billion menopausal or postmenopausal women by 2030, a population now targeted by menopause scoring features from consumer wearable makers. Oura reported more than 5.5 million rings sold by October 2025, which shows that consumer sensor hardware reaches large audiences quickly and gives women's health features a ready installed base. The market page used covers the wider femtech category, so wearable sensing is one of several revenue pools.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Women's Health Wearables and Femtech Devices Patent Filing Trends and Innovation Activity

Women's health wearables and femtech devices attract filings from consumer electronics groups, specialist femtech companies and academic laboratories. Each group files for a different layer: electronics groups cover sensors and signal processing, specialists cover algorithms and product form, and universities cover biomarkers.

The dataset contains more than 6,870 patent families, with filing peaks in 2022 and 2023 after skin temperature sensors reached mainstream smartwatches and rings. Applications on pregnancy, perimenopause and hormone biosensing form the fastest growing share of recent filings.

Rising consumer adoption of cycle, fertility and pregnancy features has pushed assignees to protect sensing methods, algorithms and product forms in parallel.

Scope of the Women's Health Wearables and Femtech Devices Patent Landscape Analysis Report

The report covers granted patents and published applications for wearable and body-worn devices that monitor or support menstrual health, fertility and contraception, pregnancy and postpartum care, lactation, menopause and pelvic health. Included technologies cover temperature, heart rate, bioimpedance, pressure and biochemical sensing, together with the algorithms that convert signals into cycle phase, fertile window or symptom scores.

The scope centres on worn hardware for women's health, and in vitro fertilisation laboratory equipment, stand-alone mobile applications and drug therapies for gynaecological conditions sit at its edge. Hardware families are tracked together with their companion algorithms where both appear in the same family.

Assignees reviewed include consumer electronics companies, ring and wristband makers, breast pump and pelvic health specialists, medical device groups, hospitals and universities.

Global Women's Health Wearables and Femtech Devices Patent Landscape Analysis

Women's Health Wearables and Femtech Devices Patent Filing Trend Analysis

Filings in women's health wearables and femtech devices grew at an estimated 14% per year during 2020 to 2024. The main driver was the move of skin temperature sensing from clinical thermometers to rings and wrist devices, which opened cycle prediction and fertility claims to consumer hardware makers.

A second wave of filings followed from 2023, tied to pregnancy insights, perimenopause scoring and wearable breast pumps. Grants reached about 1,020 in 2025, and approvals from the FDA for digital contraception and hypertension alerts in 2025 encouraged continuation filings that extend claims into adjacent use cases.

Leading Companies and Assignee Analysis in the Women's Health Wearables and Femtech Devices Patent Landscape

Geographic Analysis of Women's Health Wearables and Femtech Devices Patent Activity

The report assesses patent activity across major jurisdictions, including:

• United States
• Europe
• China
• Japan
• South Korea
• India
• International and WIPO filings

The United States leads filing volume at about 2,780 patents, supported by the FDA clearance route for contraceptive algorithms and the home of most platform owners. China follows with a high count of utility-model and device patents from electronics makers. Europe ranks third, with activity centred on Sweden, Germany, the United Kingdom and Switzerland, where several fertility and pump companies are based.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Women's Health Wearables and Femtech Devices Technology Segmentation and Innovation Areas

The report segments patent activity by the following technology areas:

• Skin temperature cycle prediction
• Fertility and contraception algorithms
• Pregnancy and postpartum monitoring
• Wearable breast pump hardware
• Menopause and pelvic health sensing

Among these, skin temperature cycle prediction holds the largest share of families, because ring and watch makers apply the same sensor claims to several cycle and fertility functions.

Competitive Landscape and Emerging Trends in the Women's Health Wearables and Femtech Devices Market

Competition spans consumer electronics giants, ring specialists and focused femtech firms. Samsung Electronics, Apple and Google file around general-purpose wearables, while Oura Health and Natural Cycles concentrate on cycle intelligence. The April 2025 acquisition of Elvie by Willow combined two wearable pump portfolios and closed a patent dispute that began in 2023.

Companies are focusing on:

• Overnight skin temperature sensing for ovulation estimation
• Digital contraception algorithms with regulatory clearance
• Perimenopause staging from cycle and biometric data
• Pregnancy insights from heart rate and sleep signals
• In-bra wearable breast pump motors and volume sensing
• Pelvic floor trainers with pressure and motion feedback
• Sweat and interstitial fluid hormone biosensors

Emerging innovation themes include menopause impact scoring, hormonal birth control support within cycle insights, hormone-sensing patches and conversational advisers that interpret cycle data. Oura announced menopause insights and hormonal birth control support in May 2026, and Natural Cycles launched a perimenopause mode and wristband in October 2025.

Strategic Insights from the Women's Health Wearables and Femtech Devices Patent Landscape

The portfolio picture shows platform owners securing sensing and algorithm claims while specialists protect product form and clinical validation. White space remains in hormone biosensing, postpartum recovery monitoring and menopause symptom prediction, where family counts are still low.

Technology segments, assignee strategies and jurisdiction trends are analysed in the report. The report provides actionable intelligence supporting:

• Intellectual property strategy
• R&D prioritisation
• Competitive benchmarking
• Technology scouting
• Licensing evaluation
• Partnership assessment
• Investment analysis
• Market entry planning
• Portfolio expansion strategy

Research Methodology for the Women's Health Wearables and Femtech Devices Patent Landscape Analysis

Patent data were collected from the USPTO, the European Patent Office, the China National Intellectual Property Administration, the Japan Patent Office, the Korean Intellectual Property Office and WIPO PATENTSCOPE. Searches ran on Cooperative Patent Classification codes A61B 5/00 (measurement for diagnostic purposes), A61B 10/00, A61B 5/48, A61H, A61F 5/44, A61M 1/06 (breast pumps) and G16H 50/20, combined with keyword strings on cycle, fertility, ovulation, pregnancy, lactation and menopause.

Records were screened for relevance, grouped into simple families, and tagged by device, application and sensing modality. Assignee names were harmonised across subsidiaries and acquired entities, including the Willow and Elvie portfolios.

The market side draws on FDA 510(k) and De Novo databases, company disclosures, clinical trial registries, WHO statistics and peer-reviewed literature. Regulatory events and product launches were matched to patent families to show how protection follows commercialisation.

Related Reports

Femtech Market

Wearable Pregnancy Devices Market

Prenatal Monitoring Devices Patent Landscape Analysis